Wolverine Trading’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-25,735
Closed -$236K 4661
2020
Q1
$169K Buy
+25,735
New +$130K ﹤0.01% 3776
2019
Q4
Sell
-16,216
Closed -$82K 4733
2019
Q3
$82K Buy
+16,216
New +$94.3K ﹤0.01% 3916
2019
Q1
Sell
-10,124
Closed -$78.8K 4639
2018
Q4
$79K Sell
10,124
-7,047
-41% -$70K ﹤0.01% 4055
2018
Q3
$222K Sell
17,171
-7,568
-31% -$94.9K ﹤0.01% 4124
2018
Q2
$174K Hold
24,739
﹤0.01% 4472
2018
Q1
$174K Sell
24,739
-9,422
-28% -$71.2K ﹤0.01% 4472
2017
Q4
$222K Buy
34,161
+14,415
+73% +$91.7K ﹤0.01% 4010
2017
Q3
$122K Buy
+19,746
New +$101K ﹤0.01% 4007
2017
Q2
Sell
-20,663
Closed -$90.6K 4356
2017
Q1
$113K Sell
20,663
-12,670
-38% -$70.8K ﹤0.01% 3782
2016
Q4
$182K Buy
33,333
+9,287
+39% +$50.8K ﹤0.01% 3814
2016
Q3
$150K Buy
24,046
+10,914
+83% +$56.7K ﹤0.01% 3992
2016
Q2
$59K Buy
+13,132
New +$57.1K ﹤0.01% 3793

Other funds holding CTSO

Wolverine Trading's CTSO Position: Q2 2020 in Review

Wolverine Trading sold out of Cytosorbents Corp (CTSO) in Q2 2020, closing a stake of 25,735 shares — an estimated $236K sold.

Wolverine Trading first reported a position in CTSO in Q2 2016 and held it in 12 quarters. The position peaked at $222K in Q3 2018. 91 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

  • Wolverine Trading reported no remaining Cytosorbents Corp position as of Q2 2020 after selling out during the quarter.
  • Wolverine Trading sold 25,735 Cytosorbents Corp shares in Q2 2020, an estimated $236K.
  • Wolverine Trading first reported a position in Cytosorbents Corp in Q2 2016 and held it in 12 quarters.
  • Wolverine Trading's Cytosorbents Corp position peaked at $222K in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.